TVARDI THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
TVARDI THERAPEUTICS, INC. (TVRD) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2016-03-11
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-09-30 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-06-30 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-03-31 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2014-09-30 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2014 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2015-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | 0.00 shares 10-Q · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | |||
| 2013-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-07 | 0.00 shares 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |